Literature DB >> 9210719

Estimating the prevalence of cancer in the United States.

A P Polednak1.   

Abstract

BACKGROUND: Few reports have estimated the prevalence of persons in the U.S. ever diagnosed with invasive cancer.
METHODS: The Connecticut Tumor Registry was used to identify all Connecticut residents ever diagnosed (1935-1994) with invasive cancer who were known to be alive in 1994. Estimated prevalence rates for Connecticut were compared with those for 1982, and were applied to the total U.S. population for selected years.
RESULTS: Some 95,361 persons ever diagnosed with invasive cancer(s) were confirmed as being alive at the end of 1994. The age-standardized prevalence rate had increased by 40% in males and 13% in females since 1982, due in part to large increases for breast, prostate, and (in females) lung carcinoma. Using the data for Connecticut, an estimated 7.1 million Americans in 1995 had ever been diagnosed with invasive cancer; projected numbers were 7.7 million for 2000 and 13.2 million for 2030.
CONCLUSIONS: The prevalence of persons ever diagnosed with invasive cancer could increase considerably in the coming decades, and numbers for elderly males could surpass those for elderly females by 2020. Although projections must be interpreted with caution, these data emphasize the need for primary prevention of cancer and for studies of cancer survivors.

Entities:  

Mesh:

Year:  1997        PMID: 9210719

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  [Prevalence of cancer in the Guadalajara health area].

Authors:  J M Alonso Gordo; A Bárcena Marugán; D Jiménez Del Val; J J Palacios Rojo; C Royo Sánchez; J Urbina Torija
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

2.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

Review 3.  Common cancers in the elderly.

Authors:  J Hansen
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

4.  Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden.

Authors:  R M Merrill
Journal:  J Epidemiol Community Health       Date:  2001-03       Impact factor: 3.710

5.  Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid.

Authors:  C Daniel Mullins; Jesse L Cooke; Junling Wang; Fadia T Shaya; Doren Van Hsu; Sandra Brooks
Journal:  J Natl Med Assoc       Date:  2004-06       Impact factor: 1.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.